VanEck Biotech ETF
BBH
NASDAQ
| Weiss Ratings | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Valuation | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $234.14 | |||
| Company Info | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | VanEck | |||
| Manager/Tenure (Years) | Peter H. Liao (14), Griffin Driscoll (2) | |||
| Website | http://www.vaneck.com | |||
| Phone Number | 800-826-1115 | |||
| Fund Information | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | VanEck Biotech ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Unaligned | |||
| Inception Date | Dec 20, 2011 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.40% | |||
| Dividend | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.83% | |||
| Asset Allocation | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.03% | |||
| Stock | 99.97% | |||
| U.S. Stock | 99.97% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.13% | |||
| 30-Day Total Return | -4.02% | |||
| 60-Day Total Return | 15.80% | |||
| 90-Day Total Return | 24.85% | |||
| Year to Date Total Return | 23.79% | |||
| 1-Year Total Return | 40.38% | |||
| 2-Year Total Return | 30.32% | |||
| 3-Year Total Return | 49.02% | |||
| 5-Year Total Return | 10.07% | |||
| Price | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $234.14 | |||
| 1-Month Low Price | $228.64 | |||
| 1-Month High Price | $244.02 | |||
| 52-Week Low Price | $161.02 | |||
| 52-Week Low Price (Date) | Sep 25, 2025 | |||
| 52-Week High Price | $244.02 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| NAV | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $228.60 | |||
| 1-Month High NAV | $244.02 | |||
| 52-Week Low NAV | $161.05 | |||
| 52-Week Low NAV (Date) | Sep 25, 2025 | |||
| 52-Week High NAV | $244.02 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| Beta / Standard Deviation | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.62 | |||
| Standard Deviation | 18.07 | |||
| Balance Sheet | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 469.37M | |||
| Operating Ratios | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.35% | |||
| Turnover Ratio | 19.00% | |||
| Performance | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 30.06% | |||
| Last Bear Market Total Return | -10.06% | |||